- Filed
- Jun 11, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Jun 5, 2025 | 22.17M sh |
| Short Term Debt | Q1 2025 · Feb 1, 2025 | $245.66M |
| Short Term Debt | Q1 2025 · May 4, 2024 | $226.1M |
| Cash And Equivalents | Q1 2025 · Feb 1, 2025 | $5.35M |
| Cash And Equivalents | Q1 2025 · May 4, 2024 | $12.96M |
| Current Liabilities | Q1 2025 · Feb 1, 2025 | $518.12M |
| Current Liabilities | Q1 2025 · May 4, 2024 | $573.22M |
| Total Liabilities | Q1 2025 · Feb 1, 2025 | $806.96M |
| Total Liabilities | Q1 2025 · May 4, 2024 | $883.19M |
| Current Assets | Q1 2025 · Feb 1, 2025 | $468M |
| Current Assets | Q1 2025 · May 4, 2024 | $509.61M |
| Total Assets | Q1 2025 · Feb 1, 2025 | $747.55M |
| Total Assets | Q1 2025 · May 4, 2024 | $848.34M |
| Shares Diluted restated | Q1 2025 · May 4, 2024 | 12.67M sh |
| Stock Repurchased | Q1 2025 · May 4, 2024 | $320K |
| Capex | Q1 2025 · May 4, 2024 | $4.69M |
| Operating Cash Flow | Q1 2025 · May 4, 2024 | −$110.76M |
| Stockholders Equity | Q1 2025 · May 4, 2024 | −$34.85M |
| Stockholders Equity | Q1 2025 · Feb 3, 2024 | −$9.02M |
| Eps Diluted restated | Q1 2025 · May 4, 2024 | −$2.98 |
| Eps Basic restated | Q1 2025 · May 4, 2024 | −$2.98 |
| Sga Expense | Q1 2025 · May 4, 2024 | $109.09M |
| Net Income | Q1 2025 · May 4, 2024 | −$37.8M |
| Operating Income | Q1 2025 · May 4, 2024 | −$27.99M |
| Gross Profit | Q1 2025 · May 4, 2024 | $92.74M |
| Revenue | Q1 2025 · May 4, 2024 | $267.88M |